AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Toxoplasmosis, a severe complication in allogeneic hematopoietic stem celltransplantation: Successful treatment strategies during a 5-year single-center experience
Authors: Roemer, E Blau, IW Basara, N Kiehl, MG Bischoff, M Gunzelmann, S Kirsten, D Sanchez, H Wocker, EL Fauser, AA
Citation: E. Roemer et al., Toxoplasmosis, a severe complication in allogeneic hematopoietic stem celltransplantation: Successful treatment strategies during a 5-year single-center experience, CLIN INF D, 32(1), 2001, pp. E1-E8
New therapeutic modalities in the treatment of graft-versus-host disease
Authors: Basara, N Kiehl, MG Fauser, AA
Citation: N. Basara et al., New therapeutic modalities in the treatment of graft-versus-host disease, CR R ONC H, 38(2), 2001, pp. 129-138
Successful treatment of thrombocytopenia and hemolytic anemia with IvIG ina patient with lupus-like syndrome after mismatched related PBSCT
Authors: Hartert, A Willenbacher, W Gunzelmann, S Roemer, E Basara, N Fauser, AA Kiehl, MG
Citation: A. Hartert et al., Successful treatment of thrombocytopenia and hemolytic anemia with IvIG ina patient with lupus-like syndrome after mismatched related PBSCT, BONE MAR TR, 27(3), 2001, pp. 337-340
Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study
Authors: Blau, IAW Basara, N Lentini, G Guenzelmann, S Kirsten, D Schmetzer, B Bischoff, M Roemer, E Kiehl, MG Fauser, AA
Citation: Iaw. Blau et al., Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study, BONE MAR TR, 27(1), 2001, pp. 27-33
Mycophenolate mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: Four years of experience
Authors: Basara, N Kiehl, MG Blau, W Romer, E Bischoff, M Schmetzer, B Kirsten, D Gunzelmann, S Fauser, AA
Citation: N. Basara et al., Mycophenolate mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: Four years of experience, TRANSPLAN P, 33(3), 2001, pp. 2121-2123
New immunosuppressants in BMT/GVHD
Authors: Basara, N Gunzelmann, S Willenbacher, W Fauser, AA Kiehl, MG
Citation: N. Basara et al., New immunosuppressants in BMT/GVHD, TRANSPLAN P, 33(3), 2001, pp. 2220-2222
Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
Authors: Willenbacher, W Basara, N Blau, IW Fauser, AA Kiehl, MG
Citation: W. Willenbacher et al., Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab, BR J HAEM, 112(3), 2001, pp. 820-823
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors
Authors: Remberger, M Ringden, O Blau, IW Ottinger, H Kremens, B Kiehl, MG Aschan, J Beelen, DW Basara, N Kumlien, G Fauser, AA Runde, V
Citation: M. Remberger et al., No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors, BLOOD, 98(6), 2001, pp. 1739-1745
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients
Authors: Kiehl, MG Basara, N
Citation: Mg. Kiehl et N. Basara, Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients, BLOOD, 98(5), 2001, pp. 1626-1626
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients
Authors: Basara, N Blau, WI Kiehl, MG Schmetzer, B Bischoff, M Kirsten, D Gunzelmann, S Fauser, AA
Citation: N. Basara et al., Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients, CLIN TRANSP, 14(2), 2000, pp. 121-126
Safety profile of mycophenolate mofetil
Authors: Basara, N Fauser, AA
Citation: N. Basara et Aa. Fauser, Safety profile of mycophenolate mofetil, BONE MAR TR, 26(12), 2000, pp. 1362-1363
Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study
Authors: Basara, N Schmetzer, B Blau, IW Bischoff, M Gunzelmann, S Kirsten, D Fauser, AA
Citation: N. Basara et al., Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study, BONE MAR TR, 25(4), 2000, pp. 371-376
Faster engraftment of neutrophils and platelets with peripheral blood stemcells from unrelated donors: a comparison with marrow transplantation
Authors: Ringden, O Remberger, M Runde, V Bornhauser, M Blau, IW Basara, N Holig, K Beelen, DW Hagglund, B Basu, O Ehninger, G Fauser, AA
Citation: O. Ringden et al., Faster engraftment of neutrophils and platelets with peripheral blood stemcells from unrelated donors: a comparison with marrow transplantation, BONE MAR TR, 25, 2000, pp. S6-S8
New strategies in the treatment of graft-versus-host disease
Authors: Basara, N Blau, IW Willenbacher, W Kiehl, MG Fauser, AA
Citation: N. Basara et al., New strategies in the treatment of graft-versus-host disease, BONE MAR TR, 25, 2000, pp. S12-S15
New strategies in GVHD prophylaxis
Authors: Kiehl, MG Shipkova, M Basara, N Blau, WI Fauser, AA
Citation: Mg. Kiehl et al., New strategies in GVHD prophylaxis, BONE MAR TR, 25, 2000, pp. S16-S19
A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study
Authors: Fauser, AA Basara, N Blau, IW Kiehl, MG
Citation: Aa. Fauser et al., A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study, BONE MAR TR, 25, 2000, pp. S27-S31
Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1)
Authors: Eckert, HG Kuhlcke, K Schilz, AJ Lindemann, C Basara, N Fauser, AA Baum, C
Citation: Hg. Eckert et al., Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1), BONE MAR TR, 25, 2000, pp. S114-S117
Second allogeneic hematopoietic stem cell transplantation as treatment forleukemia relapsing following a first transplant
Authors: Blau, IW Basara, N Bischoff, M Gunzelmann, S Romer, E Kirsten, D Schmetzer, B Kiehl, MG Fauser, AA
Citation: Iw. Blau et al., Second allogeneic hematopoietic stem cell transplantation as treatment forleukemia relapsing following a first transplant, BONE MAR TR, 25(1), 2000, pp. 41-45
Recurrent venous thrombosis in a patient with chronic lymphocytic leukemiaand acquired protein S deficiency
Authors: Miljic, P Milosevic-Jovicic, N Antunovic, P Boskovic, D Basara, N Rolovic, Z
Citation: P. Miljic et al., Recurrent venous thrombosis in a patient with chronic lymphocytic leukemiaand acquired protein S deficiency, HAEMATOLOGI, 30(1), 2000, pp. 51-54
Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite
Authors: Kiehl, MG Shipkova, M Basara, N Blau, IW Schutz, E Armstrong, VW Oellerich, M Fauser, AA
Citation: Mg. Kiehl et al., Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite, CLIN BIOCH, 33(3), 2000, pp. 203-208
Plasma thrombopoietin level in patients receiving unrelated and related bone marrow and blood stem cell transplants
Authors: Basara, N Jelkmann, W Schmetzer, B Gunzelmann, S Bischoff, M Blau, WI Kiehl, MG Fauser, AA
Citation: N. Basara et al., Plasma thrombopoietin level in patients receiving unrelated and related bone marrow and blood stem cell transplants, THROMB HAEM, 82(6), 1999, pp. 1771-1772
Modulatory in vitro effects of interleukin-1 receptor antagonist (IL-1Ra) or antisense oligonucleotide to interleukin-1 beta converting enzyme (ICE) on acute myeloid leukaemia (AML) cell growth
Authors: Stosic-Grujicic, S Basara, N Dinarello, CA
Citation: S. Stosic-grujicic et al., Modulatory in vitro effects of interleukin-1 receptor antagonist (IL-1Ra) or antisense oligonucleotide to interleukin-1 beta converting enzyme (ICE) on acute myeloid leukaemia (AML) cell growth, CLIN LAB H, 21(3), 1999, pp. 173-185
A second unrelated bone marrow transplant: successful quantitative monitoring of mixed chimerism using a highly discriminative PCR-STR system
Authors: Blau, IW Basara, N Serr, A Seidl, C Seifried, E Fuchs, M Bischoff, M Roemer, E Fauser, AA
Citation: Iw. Blau et al., A second unrelated bone marrow transplant: successful quantitative monitoring of mixed chimerism using a highly discriminative PCR-STR system, CLIN LAB H, 21(2), 1999, pp. 133-138
Peripheral blood stem cell transplantation from unrelated donors: A comparison with marrow transplantation
Authors: Ringden, O Remberger, M Runde, V Bornhauser, M Blau, IW Basara, N Holig, K Beelen, DW Hagglund, H Basu, O Ehninger, G Fauser, AA
Citation: O. Ringden et al., Peripheral blood stem cell transplantation from unrelated donors: A comparison with marrow transplantation, BLOOD, 94(2), 1999, pp. 455-464
Chronic eosinophilic leukemia: Successful treatment with an unrelated bonemarrow transplantation
Authors: Basara, N Markova, J Schmetzer, B Blau, IW Kiehl, MG Bischoff, M Kirsten, D Fauser, AA
Citation: N. Basara et al., Chronic eosinophilic leukemia: Successful treatment with an unrelated bonemarrow transplantation, LEUK LYMPH, 32(1-2), 1998, pp. 189
Risultati: 1-25 | 26-26